115 related articles for article (PubMed ID: 4216254)
1. [Laboratory safety testing of live dysentery vaccine strains (author's transl)].
Lesniak SV; Levenbuk IS; Fedotova Y; Belaya M; Yu A; Sergeev VV; Jikidze EK; Kavtaradze KN; Elkina SL
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):87-97. PubMed ID: 4216254
[No Abstract] [Full Text] [Related]
2. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
3. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
4. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
5. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
6. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
7. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
8. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
9. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
Linde K; Dentchev V; Bondarenko V; Marinova S; Randhagen B; Bratoyeva M; Tsvetanov Y; Romanova Y
Vaccine; 1990 Feb; 8(1):25-9. PubMed ID: 2180230
[TBL] [Abstract][Full Text] [Related]
10. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
[TBL] [Abstract][Full Text] [Related]
11. [Enteric dysentery vaccines and their effectiveness in a rabbit intestinal loop model. I. The residual virulence of attenuated vaccinal strains of Shigella administered into the intestinal loops].
Polotskiĭ IuE; Fedotova IuM; Rukhamina ML; Seliverstova VG
Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):32-6. PubMed ID: 7004003
[TBL] [Abstract][Full Text] [Related]
12. [Separation of Shigella enterotoxin and immunosuppression factors].
Borisov VA
Mikrobiol Zh (1978); 1988; 50(1):77-80. PubMed ID: 3074243
[No Abstract] [Full Text] [Related]
13. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
[No Abstract] [Full Text] [Related]
14. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
Rui X; Xu Y; Wan H; Su G; Huang C
Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
[TBL] [Abstract][Full Text] [Related]
15. Immunity against dysentery after enteral immunization with live vaccine.
Denchev V; Trifonova A; Jeleva M; Duncheva S; Bratanova V; Dimitrova Z; Kovachev P
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):71-4. PubMed ID: 4613140
[No Abstract] [Full Text] [Related]
16. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
[No Abstract] [Full Text] [Related]
17. Shigellosis: the current status of vaccine development.
Kweon MN
Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
20. [Live vaccines for the prevention of intestinal infections].
Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
